Form 4 for GILD Gilead Sciences
Accepted 2025-06-02 00:00:00 ET · period of report 2025-05-30 · accession 0001127602-25-016281 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-02 | 2025-05-30 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | S - Sale | $110.41 | -10.0K | 623.9K | -2% | -$1.10M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-30 | S | D | 3,584 | $110.96 | 620,268 | D | — | — | (F3) Sale prices reported for the transactions reported here range from $110.68 to $111.45. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. |
| 2 | Common | Common Stock | 2025-05-30 | S | D | 6,416 | $110.11 | 623,852 | D | — | — | (F2) Sale prices reported for the transactions reported here range from $109.68 to $110.67. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. |